The space of enzyme regulation in HeLa cells can be inferred from its intracellular metabolome

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Diener, Christian ^a   Muñoz Gonzalez, Felipe ^a   Encarnación, Sergio ^b   Resendis Antonio, Osbaldo ^a,c  

^a INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^b INSTITUTO DE CIENCIAS FÍSICAS   (Mexico)

^c Red de Apoyo A la Investigación UNAM ^*  (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ENZYME;

CAPILLARY ELECTROPHORESIS; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HELA CELL LINE; HUMAN; KINETICS; MASS SPECTROMETRY; METABOLISM; METABOLOME;

CELL LINE; CELL PROLIFERATION; ELECTROPHORESIS, CAPILLARY; ENZYMES; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; KINETICS; MASS SPECTROMETRY; METABOLOME; PHOSPHOFRUCTOKINASES;

EID: 84975783853     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28415     Document Type: Article

References (63)

1. Kim, J. W. & Dang, C. V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Research 66, 8927-8930 (2006).
2. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science (80-.). 324, 1029-1033 (2009).
3. Verhaak, R. G. W. et al. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98-110 (2010).
4. Muzny, D. M. et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
5. Koboldt, D. C. et al. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
6. Meacham, C. E. & Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature 501, 328-337 (2013).
7. Hu, J. et al. Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat. Biotechnol. 31, 522-9 (2013).
8. Bode, A. M. & Dong, Z. Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4, 793-805 (2004).
9. Thomson, J. M. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20, 2202-2207 (2006).
10. Hitosugi, T. & Chen, J. Post-translational modifications and the Warburg effect. Oncogene 33, 4279-4285 (2014).
11. Lindsley, J. E. & Rutter, J. Whence cometh the allosterome? Proc. Natl. Acad. Sci. 103, 10533-10535 (2006).
12. Chiarugi, A., Dölle, C., Felici, R. & Ziegler, M. The NAD metabolome - a key determinant of cancer cell biology. Nat. Rev. Cancer 12, 741-752 (2012).
13. Aboud, O. A. & Weiss, R. H. New Opportunities from the Cancer Metabolome. Clin. Chem. 59, 138-146 (2013).
14. Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95 (2011).
15. Sreekumar, A. et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914 (2009).
16. Zelezniak, A., Sheridan, S. & Patil, K. R. Contribution of Network Connectivity in Determining the Relationship between Gene Expression and Metabolite Concentration Changes. PLoS Comput. Biol. 10, e1003572 (2014).
17. Bordbar, A. et al. Personalized Whole-Cell Kinetic Models of Metabolism for Discovery in Genomics and Pharmacodynamics. Cell Syst. 1, 283-292 (2015).
18. Orth, J. D., Thiele, I. & Palsson, B. Ø. What is flux balance analysis? Nat. Biotechnol. 28, 245-248 (2010).
19. Agren, R. et al. Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT. PLoS Comput. Biol. 8, e1002518 (2012).
20. Agren, R. et al. Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol. 10, 721-721 (2014).
21. Yizhak, K., Chaneton, B., Gottlieb, E. & Ruppin, E. Modeling cancer metabolism on a genome scale. Mol. Syst. Biol. 11, 817-817 (2015).
22. Raamsdonk, L. M. et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol. 19, 45-50 (2001).
23. Machado, D. & Herrgard, M. Systematic Evaluation of Methods for Integration of Transcriptomic Data into Constraint-Based Models of Metabolism. PLoS Comput. Biol. 10, e1003580 (2014).
24. Famili, I., Mahadevan, R. & Palsson, B. O. k-Cone Analysis: Determining All Candidate Values for Kinetic Parameters on a Network Scale. Biophys. J. 88, 1616-1625 (2005).
25. Schellenberger, J. & Palsson, B. O. Use of Randomized Sampling for Analysis of Metabolic Networks. J. Biol. Chem. 284, 5457-5461 (2009).
26. Resendis-Antonio, O. Filling Kinetic Gaps: Dynamic Modeling of Metabolism Where Detailed Kinetic Information Is Lacking. PLoS One 4, e4967 (2009).
27. Yizhak, K. et al. Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer. Elife 3, (2014).
28. Posakony, J. W., England, J. M. & Attardi, G. Mitochondrial growth and division during the cell cycle in HeLa cells. J. Cell Biol. 74, 468-491 (1977).
29. Boukamp, P. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761-771 (1988).
30. Shi, Q. & King, R. W. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 437, 1038-1042 (2005).
31. Hirayama, A. et al. Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry. Cancer Res. 69, 4918-4925 (2009).
32. Tang, X. et al. A joint analysis of metabolomics and genetics of breast cancer. Breast Cancer Res. 16, 415 (2014).
33. Jain, M. et al. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation. Science (80-.). 336, 1040-1044 (2012).
34. Resendis-Antonio, O., Checa, A. & Encarnación, S. Modeling core metabolism in cancer cells: Surveying the topology underlying the Warburg effect. PLoS One 5 (2010).
35. Noor, E., Haraldsdóttir, H. S., Milo, R. & Fleming, R. M. T. Consistent Estimation of Gibbs Energy Using Component Contributions. PLoS Comput. Biol. 9, e1003098 (2013).
36. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47-e47 (2015).
37. Smyth, G. K. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments. Stat. Appl. Genet. Mol. Biol. 3, 1-25 (2004).
38. Mahadevan, R. & Schilling, C. H. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab. Eng. 5, 264-276 (2003).
39. Yi, W. et al. Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism. Science (80-.). 337, 975-980 (2012).
40. Webb, B. A. et al. Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations. Nature 523, 111-114 (2015).
41. Christofk, H. R. et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230-233 (2008).
42. Vander Heiden, M. G. et al. Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells. Science (80-.). 329, 1492-1499 (2010).
43. Chan, B., VanderLaan, P. A. & Sukhatme, V. P. 6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met. Biochem. Biophys. Res. Commun. 439, 247-251 (2013).
44. Gruer, M. J., Artymiuk, P. J. & Guest, J. R. The aconitase family: Three structural variations on a common theme. Trends in Biochemical Sciences 22, 3-6 (1997).
45. Tsui, K. H. et al. Hypoxia upregulates the gene expression of mitochondrial aconitase in prostate carcinoma cells. J. Mol. Endocrinol. 51, 131-141 (2013).
46. Kemp, R. G. & Foe, L. G. Allosteric regulatory properties of muscle phosphofructokinase. Mol. Cell. Biochem. 57, 147-154 (1983).
47. Barrett, T. et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 41, D991-D995 (2013).
48. Hernández Patiño, C. E., Jaime-Muñoz, G. & Resendis-Antonio, O. Systems biology of cancer: moving toward the integrative study of the metabolic alterations in cancer cells. Front. Physiol. 3, 481 (2012).
49. Hasawi, N. Al., Alkandari, M. F. & Luqmani, Y. A. Phosphofructokinase: A mediator of glycolytic flux in cancer progression. Crit. Rev. Oncol. Hematol. 92, 312-321 (2014).
50. Ralser, M. et al. Metabolic reconfiguration precedes transcriptional regulation in the antioxidant response. Nat. Biotechnol. 27, 604-605 (2009).
51. Basta, P. et al. Genetic variation in Transaldolase 1 and risk of squamous cell carcinoma of the head and neck. Cancer Detect. Prev. 32, 200-208 (2008).
52. Wang, C. et al. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples. Cancer Lett. 313, 154-166 (2011).
53. Daran-Lapujade, P. et al. The fluxes through glycolytic enzymes in Saccharomyces cerevisiae are predominantly regulated at posttranscriptional levels. Proc. Natl. Acad. Sci. USA 104, 15753-15758 (2007).
54. Link, H., Kochanowski, K. & Sauer, U. Systematic identification of allosteric protein-metabolite interactions that control enzyme activity in vivo. Nat. Biotechnol. 31, 357-361 (2013).
55. Chubukov, V. et al. Transcriptional regulation is insufficient to explain substrate-induced flux changes in Bacillus subtilis. Mol. Syst. Biol. 9, 709-709 (2014).
56. Higareda-Almaraz, J., Enríquez-Gasca, M., Hernández-Ortiz, M., Resendis-Antonio, O. & Encarnación-Guevara, S. Proteomic patterns of cervical cancer cell lines, a network perspective. BMC Syst. Biol. 5, 96 (2011).
57. Zhao, L. et al. Intracellular water-specific MR of microbead-adherent cells: The HeLa cell intracellular water exchange lifetime. NMR Biomed. 21, 159-164 (2008).
58. Wishart, D. S. et al. HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res. 41, D801-D807 (2013).
59. Avis, D. & Fukuda, K. A pivoting algorithm for convex hulls and vertex enumeration of arrangements and polyhedra. Discrete Comput. Geom. 8, 295-313 (1992).
60. Thiele, I. et al. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419-425 (2013).
61. Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B 57, pp. 289-300 (1995).
62. Rubin, D. B. The bayesian bootstrap. Ann. Stat. 9, 130-134 (1981).
63. McCall, M. N., Bolstad, B. M. & Irizarry, R. A. Frozen robust multiarray analysis (fRMA). Biostatistics 11, 242-53 (2010).